Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA.

Simple Summary: Identifying biomarkers of survival from a large-scale cohort of Glioblastoma Multiforme (GBM) pathology images is hindered by heterogeneity of tumor signature compounded by age being the single most important confounder in predicting survival in GBM. The main contributions of this ma...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancers Vol. 15; no. 8; pp. 2387 - 2402
Autores principales: Winkelmaier, Garrett, Koch, Brandon, Bogardus, Skylar, Borowsky, Alexander D., Parvin, Bahram
Formato: pictorial research tables/charts Journal Article
Publicado: MDPI Apr2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163389646&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 163389646
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        20726694
        B74B
      jtl: Cancers
      issn: 20726694
      maglogo: N
    pubinfo:
      dt: Apr2023
      vid: 15
      iid: 8
      pid: 97109
      pub: MDPI
    artinfo:
      ui:
        163389646
        163389646
        163389646
        10.3390/cancers15082387
        163389646
      ppf: 2387
      ppct: 15
      formats:
      tig:
        atl: Biomarkers of Tumor Heterogeneity in Glioblastoma Multiforme Cohort of TCGA.
      aug:
        au:
          Winkelmaier, Garrett
          Koch, Brandon
          Bogardus, Skylar
          Borowsky, Alexander D.
          Parvin, Bahram
        affil: Department of Electrical and Biomedical Engineering, College of Engineering, University of Nevada Reno, 1664 N. Virginia St., Reno, NV 89509, USA
      sug:
        subj:
          Tumor Markers, Biological
          Glioma
          Digital Imaging
          Artificial Intelligence
          Human
          Funding Source
          Tumor Cells, Cultured
          Genotype
          Phenotype
          Kaplan-Meier Estimator
          Prediction Models
          Descriptive Statistics
          Genomics
          Slides
          Image Processing, Computer Assisted
          Deep Learning
      ab: Simple Summary: Identifying biomarkers of survival from a large-scale cohort of Glioblastoma Multiforme (GBM) pathology images is hindered by heterogeneity of tumor signature compounded by age being the single most important confounder in predicting survival in GBM. The main contributions of this manuscript are to define (i) metrics for identifying tumor subtypes of tumor heterogeneity and (ii) relevant statistics for incorporating age for evaluating competing hypotheses. As a result, the GBM cohort are stratified based on interpretable morphometric features with or without preconditioning on published genomic subtypes. Tumor Whole Slide Images (WSI) are often heterogeneous, which hinders the discovery of biomarkers in the presence of confounding clinical factors. In this study, we present a pipeline for identifying biomarkers from the Glioblastoma Multiforme (GBM) cohort of WSIs from TCGA archive. The GBM cohort endures many technical artifacts while the discovery of GBM biomarkers is challenged because "age" is the single most confounding factor for predicting outcomes. The proposed approach relies on interpretable features (e.g., nuclear morphometric indices), effective similarity metrics for heterogeneity analysis, and robust statistics for identifying biomarkers. The pipeline first removes artifacts (e.g., pen marks) and partitions each WSI into patches for nuclear segmentation via an extended U-Net for subsequent quantitative representation. Given the variations in fixation and staining that can artificially modulate hematoxylin optical density (HOD), we extended Navab's Lab method to normalize images and reduce the impact of batch effects. The heterogeneity of each WSI is then represented either as probability density functions (PDF) per patient or as the composition of a dictionary predicted from the entire cohort of WSIs. For PDF- or dictionary-based methods, morphometric subtypes are constructed based on distances computed from optimal transport and linkage analysis or consensus clustering with Euclidean distances, respectively. For each inferred subtype, Kaplan–Meier and/or the Cox regression model are used to regress the survival time. Since age is the single most important confounder for predicting survival in GBM and there is an observed violation of the proportionality assumption in the Cox model, we use both age and age-squared coupled with the Likelihood ratio test and forest plots for evaluating competing statistics. Next, the PDF- and dictionary-based methods are combined to identify biomarkers that are predictive of survival. The combined model has the advantage of integrating global (e.g., cohort scale) and local (e.g., patient scale) attributes of morphometric heterogeneity, coupled with robust statistics, to reveal stable biomarkers. The results indicate that, after normalization of the GBM cohort, mean HOD, eccentricity, and cellularity are predictive of survival. Finally, we also stratified the GBM cohort as a function of EGFR expression and published genomic subtypes to reveal genomic-dependent morphometric biomarkers.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N